Intralesional Immunotherapy for Metastatic Melanoma: The Oldest and Newest Treatment in Oncology
- 1 January 2016
- journal article
- review article
- Published by Begell House Inc. Publishers in Critical Reviews™ in Oncogenesis
- Vol. 21 (1-2) , 65-73
Abstract
The last few years have yielded exciting developments in immunotherapy for cancer. The promise of cancer immunotherapy has been well known for many years, but had generally produced limited or inconsistent benefit to patients. Intralesional therapies, which are in fact one of the oldest forms of immunotherapy, are also demonstrating benefits in the modern age. This review discusses the origins of intralesional immunotherapy and its underlying rationale. It also discusses the reemergence of this mode of therapy into the modern era, which is where Donald L. Morton, subject of this edition of the journal, plays a major role. The review also discusses current areas of investigation. Given the intuitive advantages of this strategy and the demonstrated, expanding areas of clinical responses, it is likely that intralesional immunotherapy will remain a useful component of cancer treatment into the future.Keywords
This publication has 34 references indexed in Scilit:
- Tumor-Infiltrating Lymphocyte Grade in Primary Melanomas Is Independently Associated With Melanoma-Specific Survival in the Population-Based Genes, Environment and Melanoma StudyJournal of Clinical Oncology, 2013
- Combined Intralesional Bacille Calmette-Guérin (BCG) and Topical Imiquimod for In-transit MelanomaJournal of Immunotherapy, 2012
- Herpes simplex virus oncolytic vaccine therapy in melanomaExpert Opinion on Biological Therapy, 2010
- Intratumoral Interleukin-21 Increases Antitumor Immunity, Tumor-infiltrating CD8+ T-cell Density and Activity, and Enlarges Draining Lymph NodesJournal of Immunotherapy, 2010
- Effector Memory T Cells, Early Metastasis, and Survival in Colorectal CancerNew England Journal of Medicine, 2005
- Clinical responses and lymphoid infiltrates in metastatic melanoma following treatment with intralesional GM-CSFMelanoma Research, 1996
- Severe Complications of Intralesional BCG Therapy in an Unsensitized PatientArchives of Surgery, 1978
- Intralesional treatment of recurrent metastatic cutaneous malignant melanoma.A randomized prospective study of intralesional bacillus calmette-guerin versus intralesional dinitrochlorobenzeneCancer, 1978
- Regression of pulmonary metastatic disease associated with intralesional bcg therapy of intracutaneous melanoma metastasesCancer, 1975
- THE TREATMENT OF MALIGNANT TUMORS BY BACTERIAL TOXINS AS DEVELOPED BY THE LATE COLEY,WILLIAM,B., REVIEWED IN THE LIGHT OF MODERN RESEARCH1946